As noted above, mHSPCs are often high-grade tumors with several genomic mutations occurring following the initial PC diagnosis, thus it is possible that the AST/ALT ratio was not significantly increased at the time of mCRPC diagnosis, with the tumor volume reduction effect of ADT another important factor. This evidence concerns the gene GPT and neoplasm.